SCHEMBL30709174

SCHEMBL30709174

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4ccncc4-c4ccc(-n5c6ccc(-n7c8ccccc8c8ccccc87)cc6c6cc(-n7c8ccccc8c8ccccc87)ccc65)cc4)cc3)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RPS6KA3 P51812 3/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ RAC2 P15153 1/20 0.38
▸ RAC3 P60763 1/20 0.38
▸ CDC42 P60953 1/20 0.38
▸ RAC1 P63000 1/20 0.38
▸ CYP46A1 Q9Y6A2 1/20 0.37
▸ NPY5R Q15761 1/20 0.35
▸ TNF P01375 1/20 0.35
▸ MAPT P10636 3/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ HSP90AA1 P07900 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ DYRK1A Q13627 1/20 0.34
▸ CYP17A1 P05093 2/20 0.33
▸ CYP1A2 P05177 2/20 0.33
▸ PTGER4 P35408 1/20 0.33
▸ RPS6KA2 Q15349 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20771584 1.00 RPS6KA3 (0.40) RPS6KA3KDM4EATML3MBTL1RAC2
SCHEMBL30709204 0.93 RPS6KA3 (0.40) RPS6KA3KDM4EATML3MBTL1CYP46A1
SCHEMBL22126360 0.93 RPS6KA3 (0.40) RPS6KA3KDM4EATML3MBTL1CYP46A1
SCHEMBL21046108 0.91 PIK3CA (0.41) RPS6KA3CYP46A1TNFMAPTMEN1
SCHEMBL19269960 0.89 ATM (0.41) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL17952770 0.89 KDM4E (0.42) RPS6KA3KDM4EATML3MBTL1RAC2
SCHEMBL17952776 0.89 KDM4E (0.42) RPS6KA3KDM4EATML3MBTL1RAC2
SCHEMBL17952857 0.89 KDM4E (0.42) RPS6KA3KDM4EATML3MBTL1RAC2
SCHEMBL17952858 0.89 KDM4E (0.42) RPS6KA3KDM4EATML3MBTL1RAC2
SCHEMBL15606604 0.87 CYP1A2 (0.45) KDM4EATML3MBTL1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11849634-B2 Composition of matter for use in organic light- emitting diodes KYULUX, INC. (JP) 2023-12-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11849634-B2 Composition of matter for use in organic light- emitting diodes NDUFV3, NDUFV2, CRY2 RPS6KA3 3096/4885KDM4E 4409/4885ATM 2778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback